What's breaking now, across thousands of outlets.
South Africa is stepping up Ebola screening at ports of entry, preparing 36 hospitals and introducing a travel questionnaire as the Bundibugyo outbreak continues in the DRC.
We haven't written up this one. IOL has the full story — the link below goes straight to it.
For the pharmaceutical division, US approval is crucial: its bestseller Xarelto is losing sales. Asundexian is intended to fill the gap - especially in the US, where Bayer is growing the fastest.
"Brilliant, analytically rigorous, prolific, passionate about improving the way we generate and apply medical evidence, with intellectual sharpness and a relentless drive to improve science." The post…
Patients at several public healthcare facilities say they were unable to collect prescribed medicines, while the National Department of Health reports 83.4% availability nationally and promises…
